Kymab

Meditrina (B260)
Babraham Research Campus
Cambridge
CB22 3AT
United Kingdom

+44 1223 833301

Activities

R and D | Biotechnology

Related Content

Kymab antibody could be used to treat leukemia

Kymab announce promising new antibody for autoimmune treatment

Kymab new therapeutic antibody for autoimmune diseases shows potential for improvement in post-transplant survival

Kymab secures $100 million series C funding

Human antibody discovery platform successfully demonstrates steps to developing HIV vaccine

Heptares and Kymab enter into novel antibody therapeutics collaboration

Kymab secures an additional US$50m in Series B funding

Kymab and the Wellcome Trust initiate Ebola project

Kymab succeeds in revoking Regeneron’s European Patent

Kymab gives details of Kymouse technology

Jobs and People

Kymab appoints Sonia Quaratino as Chief Medical Officer

Kymab appoints Dr Arndt Schottelius as Executive VP, R&D

Kymab hires leaders in immuno-oncology, infectious disease and blood disorders

Kymab appoints Dr David Chiswell as Chief Executive

Christian Groendahl steps down as CEO of Kymab

Kymab makes two management appointments

Kymab appoints Christian Groendahl as Chief Executive

Similar Companies